How can I model large molecules like macrocycles?
What comprises large molecules? When we talk about “large molecules,” we often think of biologics like monoclonal antibodies, proteins, and…
What comprises large molecules? When we talk about “large molecules,” we often think of biologics like monoclonal antibodies, proteins, and…
Why focus on cytochrome P450 enzymes? CYPs are a ubiquitous superfamily of heme-containing monooxygenases responsible for approximately 70–80% of observed…
StarDrop — A Swiss Army knife for drug discovery It’s designed to fit right in with the other tools you…
At a very basic level, this means that StarDrop supports loading data from many different standard file formats (SDF, MOL2,…
Is AI-guided drug discovery faster and cheaper? The evidence for this is, by definition, anecdotal. No one runs the same…
What’s the purpose of a predictive model? What’s the value of predictive models for drug discovery? Most of the undergraduate…
The role of generative chemistry in drug discovery A key difficulty in finding new drugs is the sheer size of…
Discover which metabolite prediction software is best for your needs in this comprehensive guide from Optibrium. Compare top tools like Meteor Nexus, MetaSite, and StarDrop to make informed decisions for drug metabolism prediction
We’re often asked, “What’s the difference between QSAR and imputation models?”, so I’m going to explain how the methods differ, their advantages and disadvantages, and when each approach is applicable.
How number of users affect drug discovery software costs The number of people who need access to the platform is…
Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity and greater precision than
other approaches
Introduction The emergence of resistance and increased stringency of regulatory requirements have created a need for new agrochemicals. The long…
To guide drug design, it’s important to understand the likely ADME and physicochemical properties of your compounds at an early…
Develop advanced MPO strategies and target the right compounds, faster.
We’re diving back into our favourite subject: multi-parameter optimisation.
In this paper, we describe an extended benchmark for non-cognate docking of macrocyclic ligands, and the superior performance of Surflex™-Dock…